Muhlis Akman
- MEDICINA MOLECOLARE
- Dottorato: 35° ciclo
- Matricola: 911186
Contatti
- muhlis.akman@edu.unito.it
- Dipartimento di Oncologia, Università degli Studi di Torino
via Santena 5/bis, III piano - https://dott-mm.campusnet.unito.it/do/studenti.pl/Show?911186
- VCard contatti
- QRcode contatti
Supervisore
Chiara RigantiAttività di ricerca
Role of ABCB1, ABCC1 and ABCA1 transporters in chemo- and immune-resistance
- Kopecka J, Godel M, Dei S, Giampietro R, Belisario DC, Akman M, Contino M, Teodori E, Riganti C, Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death, Cells 2020,9;1033.
- Belisario DC, Akman M, Godel M, Campani V, Patrizio M P, Scotti L, Hattinger C M, De Rosa G, Donadelli M, Serra M, Kopecka J, Riganti C, ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensivity in Human Osterosarcoma, Cells 2020,9;647.
- “Exploiting Results – Science Communication and Spin-offs”, by Stratagem CA17104, 06.12.2019 Center for Experimental Research and Medical Studies (CERMS), University of Torino, Italy.
- “Carbon Based Nanomaterials: From Nanosafety to Nanomedicine/Understanding the Nanomaterials Interaction with Biomolecules, Relevance for Nanomedicine and Nanotoxicity”, 03.02.2020, Molecular Biotechnology Centre, University of Torino, Torino, Italy.
- "Pharmacology of pancreatic cancer: novel approaches using "solid & liquid" models", 02.2020, Center for Experimental Research and Medical Studies (CERMS), University of Torino, Italy.
- Corso di Lingua Italiana Livello A1-A2, 08.04.2020-24.06.2020, Corso in modalita e-learning, University of Torino, Italy